-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Apelin-36(rat-mouse)TFA
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/apelin-36-rat-mouse-tfa.gif)
| Category | Human immunodeficiency Virus (HIV) |
| Description | Apelin-36(rat, mouse) TFA is an endogenous orphan G protein-coupled receptor APJ agonist. Apelin-36(rat, mouse) TFA binds to APJ receptors with an IC50 of 5.4 nM, and potently inhibits cAMP production with an EC50 of 0.52 nM. Apelin-36(rat, mouse) TFA blocks entry of some HIV-1 and HIV-2 strains into NP-2/CD4 cells expressing APJ. |
Product Information
| Synonyms | HY-P1065A|Apelin-36(rat, mouse) (TFA) |
| Molecular Weight | 4314.91 |
| Molecular Formula | C187H305N68O45S |
| Purity | ≥99% |
| Solubility | Water |
| Appearance | Solid powder |
| Storage | -20°C, sealed |
| Target | HIV-1 HIV-2 |
